WAT
Waters Corporation · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +2 | 70.18M | $26.88B | +7 | −5 |
| Q1 2026 | 163 | +5 | 66.62M | $20.68B | +11 | −7 |
| Q4 2025 | 157 | -1 | 42.72M | $16.21B | +1 | −1 |
| Q3 2025 | 21 | +1 | 20.77M | $6.22B | +2 | −2 |
| Q2 2025 | 18 | +1 | 20.33M | $7.10B | +1 | — |
| Q1 2025 | 14 | -1 | 6.37M | $2.34B | — | −1 |
| Q4 2024 | 15 | +1 | 6.13M | $2.27B | +1 | — |
| Q3 2024 | 13 | -2 | 2.92M | $1.05B | +1 | −3 |
| Q2 2024 | 15 | — | 2.95M | $853.36M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 1.40M | — | $405.07M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.40M | — | $405.07M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Norges Bank ✦ (pasivo) | 674.83K | — | $195.78M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 293.16K | — | $85.05M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 293.16K | — | $85.05M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 132.28K | — | $38.38M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 98.86K | — | $28.68M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 81.85K | — | $23.75M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 81.85K | — | $23.75M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 81.30K | — | $23.59M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 81.30K | — | $23.59M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 50.38K | — | $14.61M | 0.2% | n/c | 1 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 48.25K | — | $14.00M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 48.25K | — | $14.00M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 48.25K | — | $14.00M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Baillie Gifford ✦ | 48.25K | — | $14.00M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 32.04K | — | $9.30M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 32.04K | — | $9.30M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 31.98K | — | $9.28M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 6.87K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 6.01K | — | $1.74M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 6.01K | — | $1.74M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 5.34K | — | $1.55M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 5.34K | — | $1.55M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Bridgewater Associates ✦ | 2.04K | — | $593,005 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,162 tenedores, 92.59M acciones, $26.09B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.